See also this year's filing and all EDGAR filings for this company.
PDF Report 0001652130_2023_Intellia_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001652130, Intellia Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 126,554,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 1,216,797,000 |
| 4 | AssetsNoncurrent | 234,869,000 |
| 5 | PropertyPlantAndEquipmentNet | 27,921,000 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 40,527,000 |
| 8 | GeneralAndAdministrativeExpense | 90,306,000 |
| 9 | ResearchAndDevelopmentExpense | 419,979,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 52,121,000 |
| 12 | remainder_NetIncome | -16,022,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,829,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 126,554,000 |
| 1 | Assets | 1,520,114,000 |
| 2 | Expenses | 510,285,000 |
| 3 | Revenues | 52,121,000 |
| 4 | StockholdersEquity | 1,393,560,000 |
| 5 | NetIncome | -474,186,000 |
| 6 | ComprehensiveNetIncome | -476,600,500 |
| 7 | BaseVar | 1,114,962,500 |
| 8 | EconomicCapitalRatio | 0.860 |